Health
Centrofarm Swings To RON1M Profit In 1Q
Romanian pharmaceuticals retailer Centrofarm (CEOF.RO) Wednesday said it swung to net profit of 1 million lei (around EUR245,000) in the first quarter, despite lower sales.
Drug Wholesaler Tamisa Trading Swings To Profit In 2010
Romanian drug wholesaler Tamisa Trading on Wednesday said it has switched to a profit of 240,000 lei (EUR58,760) in 2010, after four consecutive years of loss.
Gedeon Richter 1Q Sales In Romania Fell 18.7% To EUR33.1M
Hungarian drug maker Gedeon Richter Wednesday said its first-quarter sales in Romania were of EUR33.1 million, down 18.7% from EUR40.7 million in the year-earlier period, as the wholesale an...
Cegedim: Romania’s 1Q Pharmaceutical Market Up 2.8% To RON2.4B
The growth of Romania’s pharmaceutical market slowed in the first quarter to just 2.8%, from 4.4% in the final quarter of 2010, market research firm Cegedim said Wednesday.
Romania Remains Core Of Cancer Drug Business For Actavis
Claudio Albrecht, CEO of Actavis drug maker, with EUR1.7 billion in turnover in 2010, which owns Sindan plant in Romania, says a Swiss or an Austrian would not have the same results as the R...
Actavis Romania Plans 15%-20% Increase In Sales For 2011
Icelandic pharmaceutical group Actavis plans to increase its Romanian sales by 15%-20% this year, from EUR93 million in 2010, Actavis Group chief executive officer Claudio Albrecht said Tues...
Ranbaxy 1Q Sales In Romania Up 12.5% YY, To $27M
Indian pharmaceutical group Ranbaxy posted a 12.5% increase in its first-quarter sales in Romania, to $27 million from $24 million, according to the company's quarterly financial report rele...
Survey: 20% Of Urban Romanians Use Private Healthcare Services
More than one fifth of urban Romanians use private medical services and over two thirds of this group choose them for their better quality compared to public healthcare, according to a surve...
Four Executive Changes In Pharmaceutical Industry. Are Others Set to Follow?
Four companies in the drug industry, GlaxoSmithKline (GSK), Eli Lilly, Farmexpert and MSD, have changed their management this year, which could amount to the start of a new wave of departure...